Plaza Feed & Crop Nutrition announces Exclusive Agreement with Intralytix for Protein Live Production applications of proprietary bacteriophage kit.
TipRanks on MSN
BiomX discontinues phase 2b trial for BX004
BiomX ( ($PHGE) ) has issued an update. On December 8, 2025, BiomX Inc. announced the discontinuation of its Phase 2b clinical trial for BX004, a ...
The Sixth International Conference on Bacteriophage Research and Antimicrobial Resistance concluded at Banaras Hindu University. The two-day event, ICBRAR-2025, brought together over 250 delegates.
They’re gorgeous, dazzling, passionately pursued, and worth billions.
University of Brighton researchers are leading a national project to develop a diagnostic tool to locate human sources of ...
A collaborative study, which includes contributions from NDORMS researchers Adam Crowther and supervisor Dario Carugo, ...
TARGETED and personalised therapies are expanding into a new area, focused not just on molecular receptors or immune signatures, but on ...
Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...
Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial ...
The team developed the patches to help prevent foodborne illnesses from common but dangerous bacteria — such as E. coli and ...
For the past two years, Auburn University’s College of Agriculture has conducted research to help peach farmers combat a crop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results